Agilon Health Inc [NYSE: AGL] surged by $0.37 during the normal trading session on while it closed the day at $3.54.
Agilon Health Inc stock has also gained 5.36% of its value over the past 7 days. However, AGL stock has inclined by 69.38% in the 3 months of the year. Over the past six months meanwhile, it has lost -13.24% and gained 86.32% year-on date.
The market cap for AGL stock reached $1.46 billion, with 412.19 million shares outstanding and 303.50 million shares in the current float. Compared to the average trading volume of 4.83M shares, AGL reached a trading volume of 9001125 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Agilon Health Inc [AGL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AGL shares is $3.41 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AGL stock is a recommendation set at 2.86. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Agilon Health Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 10, 2025. While these analysts kept the previous recommendation, Needham raised their target price to Hold. The new note on the price target was released on January 10, 2025, representing the official price target for Agilon Health Inc stock.
The Average True Range (ATR) for Agilon Health Inc is set at 0.33, with the Price to Sales ratio for AGL stock in the period of the last 12 months amounting to 0.24. The Price to Book ratio for the last quarter was 3.10, with the Price to Cash per share for the same quarter was set at 0.98.
AGL stock trade performance evaluation
Agilon Health Inc [AGL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.36. With this latest performance, AGL shares gained by 4.42% in over the last four-week period, additionally sinking by -13.24% over the last 6 months – not to mention a drop of -41.39% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AGL stock in for the last two-week period is set at 56.77, with the RSI for the last a single of trading hit 57.52, and the three-weeks RSI is set at 56.86 for Agilon Health Inc [AGL]. The present Moving Average for the last 50 days of trading for this stock 2.98, while it was recorded at 3.23 for the last single week of trading, and 4.05 for the last 200 days.
Agilon Health Inc [AGL]: An insightful look at the core fundamentals
Agilon Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.27 and a Current Ratio set at 1.27.
Earnings per share (EPS) analysis for Agilon Health Inc [AGL] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AGL. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Agilon Health Inc go to 47.69%.
Agilon Health Inc [AGL]: Institutional Ownership
The top three institutional holders of AGL stocks are: CLAYTON, DUBILIER & RICE, LLC with ownership of 100.0 million shares, which is approximately 24.3149%. FMR LLC, holding 56.93 million shares of the stock with an approximate value of $$372.3 million in AGL stocks shares; and FMR LLC, currently with $$368.94 million in AGL stock with ownership which is approximately 13.7168%.
